|
Market Closed -
Singapore S.E.
04:57:45 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.1250 SGD | +16.82% |
|
-.--% | -67.11% |
| Market Cap | 20.9M 3.96M 3.11M 2.7M 2.55M 2.31M 4.33M 299M 4.36M 30.42M 11.7M 151M 11.69M 11.43M 483M | P/E 2024 |
11.1x | P/E 2025 | -15.3x |
|---|---|---|---|---|---|
| Enterprise Value | 32.29M 6.12M 4.81M 4.16M 3.94M 3.57M 6.69M 461M 6.74M 46.99M 18.08M 234M 18.06M 17.66M 746M | EV / Sales 2024 |
1.62x | EV / Sales 2025 | 1.76x |
| Free-Float |
21.36% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +16.82% | ||
| 3 months | -65.75% | ||
| 6 months | -64.79% | ||
| Current year | -67.11% |
| Current year | 0.08 |  | 0.42 |
| 1 year | 0.08 | | 0.45 |
| 3 years | 0.06 | | 0.7 |
| 5 years | 0.06 | | 0.7 |
| 10 years | 0.06 | | 0.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xue Dan Wu
CEO | Chief Executive Officer | 63 | 2017-12-30 |
Pei Chan Tang
SEC | Corporate Secretary | - | - |
Moi Heyang Lin
SEC | Corporate Secretary | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Heng Ching Chew
CHM | Chairman | 75 | 2009-01-04 |
Xue Dan Wu
BRD | Director/Board Member | 63 | 2004-04-15 |
Yong Teng Seow
BRD | Director/Board Member | 51 | 2023-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +16.82% | -.--% | -72.53% | +25.00% | 3.11M | |
| -0.19% | +1.09% | +51.85% | +97.36% | 1,013B | |
| +0.33% | -0.71% | +50.62% | +65.50% | 644B | |
| +0.49% | +5.73% | +20.88% | +72.92% | 465B | |
| +0.32% | +4.34% | +40.40% | +40.65% | 352B | |
| +0.77% | +2.74% | +18.41% | +24.67% | 264B | |
| +0.40% | +4.60% | +7.40% | +13.59% | 253B | |
| -1.53% | -4.46% | +36.90% | +44.08% | 203B | |
| +0.47% | -4.15% | -22.89% | -57.43% | 188B | |
| -0.08% | -0.23% | +30.00% | +93.34% | 181B | |
| Average | +1.97% | -0.98% | +16.10% | +41.97% | 356.37B | |
| Weighted average by Cap. | +0.65% | +0.01% | +34.90% | +60.04% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 67.65M 12.82M 10.07M 8.73M 8.25M 7.47M 14.02M 966M 14.13M 98.47M 37.88M 490M 37.84M 37M 1.56B | 43.75M 8.29M 6.52M 5.64M 5.34M 4.83M 9.07M 625M 9.14M 63.68M 24.5M 317M 24.47M 23.93M 1.01B |
| Net income | 8.28M 1.57M 1.23M 1.07M 1.01M 914K 1.72M 118M 1.73M 12.05M 4.64M 59.96M 4.63M 4.53M 191M | -4.3M -815K -640K -555K -525K -475K -891K -61.44M -898K -6.26M -2.41M -31.15M -2.41M -2.35M -99.35M |
| Net Debt | 11.66M 2.21M 1.74M 1.5M 1.42M 1.29M 2.42M 167M 2.43M 16.97M 6.53M 84.45M 6.52M 6.38M 269M | 11.38M 2.16M 1.7M 1.47M 1.39M 1.26M 2.36M 163M 2.38M 16.57M 6.37M 82.45M 6.37M 6.23M 263M |
Employees
1,096
Sector
Pharmaceuticals
- Stock Market
- Stocks
- BFK Stock
Select your edition
All financial news and data tailored to specific country editions
